PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
Personalized medicine is one of the main directions in current cancer care. To support this trend, Modulight has designed a laser illumination platform with real-time spectral monitoring to adjust treatments based on each patient’s optical properties of the tissue, providing more personalization to light-based treatments. The laser has been designed to illuminate and retrieve spectral data from the tumor tissue simultaneously from up to eight different locations. The medical laser is cloud-connected, and all diagnostic data is downloaded in real time into the analytics server to assist in the personalized treatment decisions. This enables machine learning and AI-based data analytics to process recorded data to make more informed treatment decisions and deliver the best treatment outcomes to patients. The laser with this optical monitoring feature is currently being evaluated in glioblastoma trials where illumination can be tailored through spectral monitoring of the fluorescent drug and optical properties of the treated tissue.
Visa Kaivosoja,Robert Perttilä,Elias Kokko,Timo Tanila,Zoe Ylöniemi, andPetteri Uusimaa
"Laser illumination platform for real-time analytics and improvement of treatment efficacy", Proc. SPIE 11949, Advanced Biomedical and Clinical Diagnostic and Surgical Guidance Systems XX, 1194903 (7 March 2022); https://doi.org/10.1117/12.2608711
ACCESS THE FULL ARTICLE
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The alert did not successfully save. Please try again later.
Visa Kaivosoja, Robert Perttilä, Elias Kokko, Timo Tanila, Zoe Ylöniemi, Petteri Uusimaa, "Laser illumination platform for real-time analytics and improvement of treatment efficacy," Proc. SPIE 11949, Advanced Biomedical and Clinical Diagnostic and Surgical Guidance Systems XX, 1194903 (7 March 2022); https://doi.org/10.1117/12.2608711